Jump to content

Iduronate-2-sulfatase

From Wikipedia, the free encyclopedia
IDS
Identifiers
AliasesIDS, MPS2, Siduronate 2-sulfatase, ID2S
External IDsOMIM: 300823; MGI: 96417; GeneCards: IDS
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
3.1.6.13↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000202
NM_001166550
NM_006123

NM_001038990
NM_001038991
NM_010498

RefSeq (protein)

NP_000193
NP_001160022
NP_006114

Location (UCSC)Chr X: 149.48 – 149.52 MbChr X: 69.39 – 69.41 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Iduronate 2-sulfatase (EC 3.1.6.13; systematic name L-iduronate-2-sulfate 2-sulfohydrolase) is an enzyme that in humans is encoded by the IDS gene. This sulfatase enzyme is associated with Hunter syndrome.[5] It catalyses hydrolysis of the 2-sulfate groups of the L-iduronate 2-sulfate units of dermatan sulfate, heparan sulfate and heparin.

Function

[edit]

Iduronate 2-sulfatase is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this X-chromosome gene that result in enzymatic deficiency lead to the sex-linked mucopolysaccharidosis type II, also known as Hunter syndrome. At least 174 disease-causing mutations in this gene have been discovered.[6] Iduronate-2-sulfatase has a strong sequence homology with human arylsulfatases A, B, and C, and human glucosamine-6-sulfatase. A splice variant of this gene has been described.[5]

See also

[edit]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000010404 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000035847 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 "Entrez Gene: IDS iduronate 2-sulfatase (Hunter syndrome)".
  6. ↑ Šimčíková D, Heneberg P (December 2019). "Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases". Scientific Reports. 9 (1) 18577. Bibcode:2019NatSR...918577S. doi:10.1038/s41598-019-54976-4. PMC 6901466. PMID 31819097.

Further reading

[edit]
[edit]